Skip to Main Content

Paper Details

Loss of HER2 in breast cancer: biological mechanisms and technical pitfalls.
Cancer Drug Resist
8
2022
Author NameAffiliation
Giuseppe CuriglianoEuropean Institute of Oncology IRCCS
Giuseppe CuriglianoUniversity of Milano
Nicola FuscoUniversity of Milano
Nicola FuscoEuropean Institute of Oncology IRCCS
Nicola FuscoEuropean Institute of Oncology IRCCS
Carmen CriscitielloEuropean Institute of Oncology IRCCS
Carmen CriscitielloUniversity of Milano
  • 1 - 7

Datasets

Release 1.2